25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BERYL DRUGS LTD.
Buy, Hold or Sell?

Let's analyze BERYL DRUGS LTD. together

I guess you are interested in BERYL DRUGS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BERYL DRUGS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about BERYL DRUGS LTD.

I send you an email if I find something interesting about BERYL DRUGS LTD..

1. Quick Overview

1.1. Quick analysis of BERYL DRUGS LTD. (30 sec.)










1.2. What can you expect buying and holding a share of BERYL DRUGS LTD.? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
INR17.59
Expected worth in 1 year
INR24.35
How sure are you?
83.3%

+ What do you gain per year?

Total Gains per Share
INR6.76
Return On Investment
20.1%

For what price can you sell your share?

Current Price per Share
INR33.58
Expected price per share
INR28.70 - INR46.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of BERYL DRUGS LTD. (5 min.)




Live pricePrice per Share (EOD)
INR33.58
Intrinsic Value Per Share
INR-4.24 - INR34.08
Total Value Per Share
INR13.35 - INR51.68

2.2. Growth of BERYL DRUGS LTD. (5 min.)




Is BERYL DRUGS LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$1m$951.8k$101.1k9.6%

How much money is BERYL DRUGS LTD. making?

Current yearPrevious yearGrowGrow %
Making money$90.6k$90.3k306.800.3%
Net Profit Margin2.9%2.9%--

How much money comes from the company's main activities?

2.3. Financial Health of BERYL DRUGS LTD. (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of BERYL DRUGS LTD.?

Welcome investor! BERYL DRUGS LTD.'s management wants to use your money to grow the business. In return you get a share of BERYL DRUGS LTD..

First you should know what it really means to hold a share of BERYL DRUGS LTD.. And how you can make/lose money.

Speculation

The Price per Share of BERYL DRUGS LTD. is INR33.58. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of BERYL DRUGS LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in BERYL DRUGS LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR17.59. Based on the TTM, the Book Value Change Per Share is INR1.69 per quarter. Based on the YOY, the Book Value Change Per Share is INR1.52 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of BERYL DRUGS LTD..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.020.1%0.020.1%0.020.1%0.010.0%0.010.0%
Usd Book Value Change Per Share0.020.1%0.020.1%0.020.1%0.010.0%0.030.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.020.1%0.020.1%0.020.1%0.010.0%0.030.1%
Usd Price Per Share0.35-0.35-0.14-0.15-0.14-
Price to Earnings Ratio19.35-19.35-8.05-14.40-13.20-
Price-to-Total Gains Ratio17.36-17.36-7.98-9.41-7.93-
Price to Book Ratio1.67-1.67-0.76-0.76-0.73-
Price-to-Total Gains Ratio17.36-17.36-7.98-9.41-7.93-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.396244
Number of shares2523
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.020.01
Usd Total Gains Per Share0.020.01
Gains per Quarter (2523 shares)50.3116.38
Gains per Year (2523 shares)201.2365.52
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1020119106656
204023920131122
306045930197188
408057940262254
5010069950328320
60120711960393386
70140913970459452
80161015980524518
90181117990590584
100201220000655650

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%5.01.00.083.3%5.01.00.083.3%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%5.01.00.083.3%5.01.00.083.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.06.00.0%0.00.06.00.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%5.01.00.083.3%5.01.00.083.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of BERYL DRUGS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.6901.6900%1.524+11%0.550+207%2.932-42%
Book Value Per Share--17.59417.5940%15.905+11%15.710+12%15.566+13%
Current Ratio--1.7761.7760%1.630+9%1.403+27%1.334+33%
Debt To Asset Ratio--0.4900.4900%0.539-9%0.549-11%0.538-9%
Debt To Equity Ratio--0.9600.9600%1.171-18%1.229-22%1.180-19%
Dividend Per Share----0%-0%-0%-0%
Eps--1.5151.5150%1.510+0%0.459+230%0.576+163%
Free Cash Flow Per Share---1.048-1.0480%1.632-164%-1.180+13%-1.853+77%
Free Cash Flow To Equity Per Share---1.048-1.0480%1.632-164%-0.523-50%-0.774-26%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--34.082--------
Intrinsic Value_10Y_min---4.241--------
Intrinsic Value_1Y_max--0.434--------
Intrinsic Value_1Y_min---1.000--------
Intrinsic Value_3Y_max--3.576--------
Intrinsic Value_3Y_min---2.524--------
Intrinsic Value_5Y_max--9.458--------
Intrinsic Value_5Y_min---3.511--------
Market Cap--148752961.000148752961.0000%61671872.000+141%63091948.000+136%59643192.000+149%
Net Profit Margin--0.0290.0290%0.029+1%0.007+338%0.013+117%
Operating Margin----0%-0%0.008-100%0.018-100%
Operating Ratio--1.4371.4370%1.488-3%1.605-11%1.611-11%
Pb Ratio1.909+13%1.6671.6670%0.765+118%0.765+118%0.731+128%
Pe Ratio22.158+13%19.35419.3540%8.051+140%14.400+34%13.196+47%
Price Per Share33.580+13%29.33029.3300%12.160+141%12.440+136%11.760+149%
Price To Free Cash Flow Ratio-32.049-14%-27.993-27.9930%7.452-476%-6.464-77%-5.654-80%
Price To Total Gains Ratio19.873+13%17.35717.3570%7.981+117%9.408+84%7.934+119%
Quick Ratio--1.4111.4110%1.136+24%0.845+67%0.831+70%
Return On Assets--0.0440.0440%0.044+0%0.013+231%0.018+147%
Return On Equity--0.0860.0860%0.095-9%0.025+238%0.034+151%
Total Gains Per Share--1.6901.6900%1.524+11%0.550+207%2.932-42%
Usd Book Value--1052949.4001052949.4000%951823.400+11%940178.903+12%931535.050+13%
Usd Book Value Change Per Share--0.0200.0200%0.018+11%0.006+207%0.035-42%
Usd Book Value Per Share--0.2080.2080%0.188+11%0.185+12%0.184+13%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0180.0180%0.018+0%0.005+230%0.007+163%
Usd Free Cash Flow---62705.200-62705.2000%97656.800-164%-70633.542+13%-110886.630+77%
Usd Free Cash Flow Per Share---0.012-0.0120%0.019-164%-0.014+13%-0.022+77%
Usd Free Cash Flow To Equity Per Share---0.012-0.0120%0.019-164%-0.006-50%-0.009-26%
Usd Market Cap--1755284.9401755284.9400%727728.090+141%744484.986+136%703789.666+149%
Usd Price Per Share0.396+13%0.3460.3460%0.143+141%0.147+136%0.139+149%
Usd Profit--90694.80090694.8000%90388.000+0%27450.128+230%34492.965+163%
Usd Revenue--3154092.8003154092.8000%3170778.000-1%2229389.165+41%2106401.639+50%
Usd Total Gains Per Share--0.0200.0200%0.018+11%0.006+207%0.035-42%
 EOD+3 -3MRQTTM+0 -0YOY+22 -105Y+27 -610Y+23 -10

3.3 Fundamental Score

Let's check the fundamental score of BERYL DRUGS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1522.158
Price to Book Ratio (EOD)Between0-11.909
Net Profit Margin (MRQ)Greater than00.029
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.411
Current Ratio (MRQ)Greater than11.776
Debt to Asset Ratio (MRQ)Less than10.490
Debt to Equity Ratio (MRQ)Less than10.960
Return on Equity (MRQ)Greater than0.150.086
Return on Assets (MRQ)Greater than0.050.044
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of BERYL DRUGS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose34.980
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About BERYL DRUGS LTD.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit BERYL DRUGS LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare BERYL DRUGS LTD. to the  industry mean.
  • A Net Profit Margin of 2.9% means that ₹0.03 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BERYL DRUGS LTD.:

  • The MRQ is 2.9%. The company is making a profit. +1
  • The TTM is 2.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.9%TTM2.9%0.0%
TTM2.9%YOY2.9%+0.0%
TTM2.9%5Y0.7%+2.2%
5Y0.7%10Y1.3%-0.7%
4.3.1.2. Return on Assets

Shows how efficient BERYL DRUGS LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare BERYL DRUGS LTD. to the  industry mean.
  • 4.4% Return on Assets means that BERYL DRUGS LTD. generated ₹0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BERYL DRUGS LTD.:

  • The MRQ is 4.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.4%TTM4.4%0.0%
TTM4.4%YOY4.4%+0.0%
TTM4.4%5Y1.3%+3.1%
5Y1.3%10Y1.8%-0.5%
4.3.1.3. Return on Equity

Shows how efficient BERYL DRUGS LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare BERYL DRUGS LTD. to the  industry mean.
  • 8.6% Return on Equity means BERYL DRUGS LTD. generated ₹0.09 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BERYL DRUGS LTD.:

  • The MRQ is 8.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 8.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ8.6%TTM8.6%0.0%
TTM8.6%YOY9.5%-0.9%
TTM8.6%5Y2.5%+6.1%
5Y2.5%10Y3.4%-0.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of BERYL DRUGS LTD..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient BERYL DRUGS LTD. is operating .

  • Measures how much profit BERYL DRUGS LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare BERYL DRUGS LTD. to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BERYL DRUGS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y0.8%-0.8%
5Y0.8%10Y1.8%-1.0%
4.3.2.2. Operating Ratio

Measures how efficient BERYL DRUGS LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.44 means that the operating costs are ₹1.44 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of BERYL DRUGS LTD.:

  • The MRQ is 1.437. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.437. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.437TTM1.4370.000
TTM1.437YOY1.488-0.052
TTM1.4375Y1.605-0.169
5Y1.60510Y1.611-0.006
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of BERYL DRUGS LTD..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if BERYL DRUGS LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.78 means the company has ₹1.78 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of BERYL DRUGS LTD.:

  • The MRQ is 1.776. The company is able to pay all its short-term debts. +1
  • The TTM is 1.776. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.776TTM1.7760.000
TTM1.776YOY1.630+0.146
TTM1.7765Y1.403+0.373
5Y1.40310Y1.334+0.069
4.4.3.2. Quick Ratio

Measures if BERYL DRUGS LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare BERYL DRUGS LTD. to the  industry mean.
  • A Quick Ratio of 1.41 means the company can pay off ₹1.41 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BERYL DRUGS LTD.:

  • The MRQ is 1.411. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.411. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.411TTM1.4110.000
TTM1.411YOY1.136+0.275
TTM1.4115Y0.845+0.566
5Y0.84510Y0.831+0.014
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of BERYL DRUGS LTD..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of BERYL DRUGS LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare BERYL DRUGS LTD. to industry mean.
  • A Debt to Asset Ratio of 0.49 means that BERYL DRUGS LTD. assets are financed with 49.0% credit (debt) and the remaining percentage (100% - 49.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BERYL DRUGS LTD.:

  • The MRQ is 0.490. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.490. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.490TTM0.4900.000
TTM0.490YOY0.539-0.050
TTM0.4905Y0.549-0.059
5Y0.54910Y0.538+0.011
4.5.4.2. Debt to Equity Ratio

Measures if BERYL DRUGS LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare BERYL DRUGS LTD. to the  industry mean.
  • A Debt to Equity ratio of 96.0% means that company has ₹0.96 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BERYL DRUGS LTD.:

  • The MRQ is 0.960. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.960. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.960TTM0.9600.000
TTM0.960YOY1.171-0.211
TTM0.9605Y1.229-0.269
5Y1.22910Y1.180+0.049
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings BERYL DRUGS LTD. generates.

  • Above 15 is considered overpriced but always compare BERYL DRUGS LTD. to the  industry mean.
  • A PE ratio of 19.35 means the investor is paying ₹19.35 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BERYL DRUGS LTD.:

  • The EOD is 22.158. Based on the earnings, the company is fair priced.
  • The MRQ is 19.354. Based on the earnings, the company is fair priced.
  • The TTM is 19.354. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD22.158MRQ19.354+2.804
MRQ19.354TTM19.3540.000
TTM19.354YOY8.051+11.303
TTM19.3545Y14.400+4.954
5Y14.40010Y13.196+1.204
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BERYL DRUGS LTD.:

  • The EOD is -32.049. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -27.993. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -27.993. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-32.049MRQ-27.993-4.056
MRQ-27.993TTM-27.9930.000
TTM-27.993YOY7.452-35.445
TTM-27.9935Y-6.464-21.528
5Y-6.46410Y-5.654-0.810
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of BERYL DRUGS LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 1.67 means the investor is paying ₹1.67 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of BERYL DRUGS LTD.:

  • The EOD is 1.909. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.667. Based on the equity, the company is underpriced. +1
  • The TTM is 1.667. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.909MRQ1.667+0.242
MRQ1.667TTM1.6670.000
TTM1.667YOY0.765+0.902
TTM1.6675Y0.765+0.902
5Y0.76510Y0.731+0.034
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets174,862
Total Liabilities85,629
Total Stockholder Equity89,233
 As reported
Total Liabilities 85,629
Total Stockholder Equity+ 89,233
Total Assets = 174,862

Assets

Total Assets174,862
Total Current Assets102,218
Long-term Assets72,651
Total Current Assets
Cash And Cash Equivalents 1,249
Short-term Investments 5,364
Net Receivables 75,839
Inventory 12,602
Other Current Assets 7,164
Total Current Assets  (as reported)102,218
Total Current Assets  (calculated)102,218
+/-0
Long-term Assets
Property Plant Equipment 59,614
Intangible Assets 9
Long-term Assets Other 7,734
Long-term Assets  (as reported)72,651
Long-term Assets  (calculated)67,357
+/- 5,294

Liabilities & Shareholders' Equity

Total Current Liabilities57,554
Long-term Liabilities28,075
Total Stockholder Equity89,233
Total Current Liabilities
Short Long Term Debt 26,901
Accounts payable 20,161
Other Current Liabilities 5,648
Total Current Liabilities  (as reported)57,554
Total Current Liabilities  (calculated)52,710
+/- 4,844
Long-term Liabilities
Long term Debt 24,038
Long-term Liabilities Other -7
Long-term Liabilities  (as reported)28,075
Long-term Liabilities  (calculated)24,031
+/- 4,044
Total Stockholder Equity
Total Stockholder Equity (as reported)89,233
Total Stockholder Equity (calculated)0
+/- 89,233
Other
Capital Stock50,937
Common Stock Shares Outstanding 5,072
Net Debt 49,690
Net Invested Capital 140,172
Net Working Capital 44,664



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
145,707
169,118
186,483
178,238
175,114
174,862
174,862175,114178,238186,483169,118145,70700
   > Total Current Assets 
68,598
70,142
54,759
75,137
101,523
105,321
103,165
102,218
102,218103,165105,321101,52375,13754,75970,14268,598
       Cash And Cash Equivalents 
0
0
998
3,963
4,521
2,714
2,830
1,249
1,2492,8302,7144,5213,96399800
       Short-term Investments 
0
0
0
0
2,022
4,002
2,908
5,364
5,3642,9084,0022,0220000
       Net Receivables 
30,798
50,972
42,025
35,156
45,408
44,485
69,002
75,839
75,83969,00244,48545,40835,15642,02550,97230,798
       Inventory 
26,741
13,473
7,638
11,573
22,689
29,782
10,547
12,602
12,60210,54729,78222,68911,5737,63813,47326,741
       Other Current Assets 
3,484
2,334
2,909
22,493
1,432
667
833
7,164
7,1648336671,43222,4932,9092,3343,484
   > Long-term Assets 
0
0
90,948
93,980
84,960
72,917
71,950
72,651
72,65171,95072,91784,96093,98090,94800
       Property Plant Equipment 
20,346
21,133
80,472
83,334
73,242
58,595
58,102
59,614
59,61458,10258,59573,24283,33480,47221,13320,346
       Intangible Assets 
0
0
76
71
39
21
12
9
9122139717600
       Long-term Assets Other 
0
0
1,705
1,738
2
1
2
7,734
7,7342121,7381,70500
> Total Liabilities 
0
0
70,426
92,863
107,189
105,302
94,451
85,629
85,62994,451105,302107,18992,86370,42600
   > Total Current Liabilities 
42,419
39,081
55,345
66,277
82,133
84,925
63,289
57,554
57,55463,28984,92582,13366,27755,34539,08142,419
       Short Long Term Debt 
0
0
19,470
29,227
31,374
36,184
18,228
26,901
26,90118,22836,18431,37429,22719,47000
       Accounts payable 
11,559
14,541
17,902
18,021
22,202
30,570
32,477
20,161
20,16132,47730,57022,20218,02117,90214,54111,559
       Other Current Liabilities 
12,878
9,410
16,953
4,400
15,987
-2
7,315
5,648
5,6487,315-215,9874,40016,9539,41012,878
   > Long-term Liabilities 
0
0
15,081
26,586
25,056
20,377
31,162
28,075
28,07531,16220,37725,05626,58615,08100
> Total Stockholder Equity
0
0
75,281
76,255
79,294
72,936
80,664
89,233
89,23380,66472,93679,29476,25575,28100
   Retained Earnings 
7,931
20,138
26,046
26,525
28,921
22,331
29,992
0
029,99222,33128,92126,52526,04620,1387,931
   Accumulated Other Comprehensive Income 00000000
   Capital Surplus 00000000
   Treasury Stock00000000



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue267,296
Cost of Revenue-131,464
Gross Profit135,832135,832
 
Operating Income (+$)
Gross Profit135,832
Operating Expense-252,564
Operating Income14,732-116,732
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense252,5640
 
Net Interest Income (+$)
Interest Income0
Interest Expense-4,635
Other Finance Cost-0
Net Interest Income-4,635
 
Pretax Income (+$)
Operating Income14,732
Net Interest Income-4,635
Other Non-Operating Income Expenses0
Income Before Tax (EBT)10,09714,732
EBIT - interestExpense = -4,635
7,686
12,321
Interest Expense4,635
Earnings Before Interest and Taxes (EBIT)014,732
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax10,097
Tax Provision-2,411
Net Income From Continuing Ops7,6867,686
Net Income7,686
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net04,635
 

Technical Analysis of BERYL DRUGS LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of BERYL DRUGS LTD.. The general trend of BERYL DRUGS LTD. is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine BERYL DRUGS LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BERYL DRUGS LTD..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 41.50 < 46.00.

The bearish price targets are: 31.50 > 29.74 > 28.70.

Tweet this
BERYL DRUGS LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BERYL DRUGS LTD.. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BERYL DRUGS LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BERYL DRUGS LTD..

BERYL DRUGS LTD. Daily Moving Average Convergence/Divergence (MACD) ChartBERYL DRUGS LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BERYL DRUGS LTD.. The current adx is .

BERYL DRUGS LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BERYL DRUGS LTD..

BERYL DRUGS LTD. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BERYL DRUGS LTD..

BERYL DRUGS LTD. Daily Relative Strength Index (RSI) ChartBERYL DRUGS LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BERYL DRUGS LTD..

BERYL DRUGS LTD. Daily Stochastic Oscillator ChartBERYL DRUGS LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BERYL DRUGS LTD..

BERYL DRUGS LTD. Daily Commodity Channel Index (CCI) ChartBERYL DRUGS LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BERYL DRUGS LTD..

BERYL DRUGS LTD. Daily Chande Momentum Oscillator (CMO) ChartBERYL DRUGS LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BERYL DRUGS LTD..

BERYL DRUGS LTD. Daily Williams %R ChartBERYL DRUGS LTD. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BERYL DRUGS LTD..

BERYL DRUGS LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BERYL DRUGS LTD..

BERYL DRUGS LTD. Daily Average True Range (ATR) ChartBERYL DRUGS LTD. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BERYL DRUGS LTD..

BERYL DRUGS LTD. Daily On-Balance Volume (OBV) ChartBERYL DRUGS LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BERYL DRUGS LTD..

BERYL DRUGS LTD. Daily Money Flow Index (MFI) ChartBERYL DRUGS LTD. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BERYL DRUGS LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-30MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

BERYL DRUGS LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BERYL DRUGS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose34.980
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of BERYL DRUGS LTD. with someone you think should read this too:
  • Are you bullish or bearish on BERYL DRUGS LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about BERYL DRUGS LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BERYL DRUGS LTD.

I send you an email if I find something interesting about BERYL DRUGS LTD..


Comments

How you think about this?

Leave a comment

Stay informed about BERYL DRUGS LTD..

Receive notifications about BERYL DRUGS LTD. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.